NASDAQ$TELA

TELA Bio Inc · Q2 2018 earnings

Q2 2018 earnings · · Investor relations

Headline financials

Total Revenue

$1.82M

No prior period
EPS (adj)

-$21.89

No prior period
Net Income

-$6.45M

No prior period
Operating Income

-$4.88M

No prior period
Gross Profit

$590K

No prior period
R&D Expense

$1.16M

No prior period

Revenue & EPS history

TELA Bio · Revenue · Quarterly

$1.82M

Q2 2018
Beat estimate in 7 of 9 quarters(78%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

-2.5%

Avg return

Earnings day

-3.7%

Avg return

5 days after

+3.7%

Avg return

30 days after

42%

11 / 26 earnings

Positive

+20.2%

Q1 2024

Best reaction

-37.2%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-5.3%-18.6%
Q4 2025+1.7%-25.8%-12.0%
Q3 2025-9.3%-2.7%+3.6%
Q1 2025+7.2%-0.1%+90.7%
Q4 2024-37.2%-44.9%-59.1%
Q3 2024+2.0%+3.0%-1.7%
Q2 2024-23.9%-23.4%-35.0%
Q1 2024+20.2%+21.2%+16.7%
Q4 2023+4.0%+0.9%-13.8%
Q3 2023-20.3%-21.7%-4.5%
Q2 2023-4.8%-1.2%-2.8%
Q1 2023-3.6%-4.8%+11.2%
Q4 2022-5.5%-3.7%-11.3%
Q3 2022+13.8%+11.2%+44.7%
Q2 2022-6.5%+5.5%+0.9%
Q1 2022-5.7%-7.0%-31.4%
Q4 2021-4.8%-4.8%-20.4%
Q3 2021-3.8%-3.7%-1.7%
Q2 2021+5.0%+4.4%-8.3%
Q1 2021+3.2%+11.5%+5.9%
Q4 2020-6.6%+0.9%-1.8%
Q3 2020-3.5%-0.8%-3.6%
Q2 2020+5.4%+4.1%+20.7%
Q1 2020-2.4%-3.6%+38.6%
Q4 2019+0.6%-0.4%+34.0%
Q3 2019+13.9%+8.8%+32.6%
Q2 2019
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro